Relapsed/Refractory Multiple Myeloma Algorithm

home / treatment-algorithms-with-the-oncology-brothers / relapsed-refractory-multiple-myeloma-algorithm

Samer A. Al'Hadidi, MD joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to have a comprehensive discussion on the treatment algorithm for relapsed/refractory multiple myeloma.

Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD

EP. 1: Monitoring Patients with Relapsed/Refractory Multiple Myeloma

Rahul Gosain, MD;Rohit Gosain, MD;Samer A. Al'Hadidi, MD
May 13th 2024

Samer Al'Hadidi, MD, discusses monitoring strategies for patients with relapsed/refractory multiple myeloma who are receiving lenalidomide.

Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD

EP. 2: The Role of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Rahul Gosain, MD;Rohit Gosain, MD;Samer A. Al'Hadidi, MD
May 13th 2024

An expert on the treatment of multiple myeloma discusses the role of CAR T-cell therapy in relapsed/refractory disease.

Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD

EP. 3: Adverse Effect Management for CAR T-Cell Therapy and Bispecifics in R/R MM

Rahul Gosain, MD;Rohit Gosain, MD;Samer A. Al'Hadidi, MD
May 13th 2024

In a discussion with the Oncology Brothers on the treatment of patients with relapsed/refractory multiple myeloma, Samer Al'Hadidi, MD, discusses adverse effects associated with CAR T-cell therapy and bispecific antibodies.

Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD

EP. 4: Treatment Decision-Making in Relapsed/Refractory Multiple Myeloma

Rahul Gosain, MD;Rohit Gosain, MD;Samer A. Al'Hadidi, MD
May 13th 2024

Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Samer Al'Hadidi, MD, to discuss treatment decision-making strategies for patients with relapsed/refractory multiple myeloma.

Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD

EP. 5: Advice for Community Oncologists Treating R/R Multiple Myeloma

Rahul Gosain, MD;Rohit Gosain, MD;Samer A. Al'Hadidi, MD
May 13th 2024

Samer Al'Hadidi, MD, offers advice to community oncologists who treat patients with relapsed/refractory multiple myeloma, and the Oncology Brothers recap the entire discussion.